BOK Financial Private Wealth’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-80
Closed -$5.31K 470
2025
Q4
$5.31K Buy
+80
New +$5.17K ﹤0.01% 414
2024
Q4
Sell
-166
Closed -$11.1K 660
2024
Q3
$11.1K Sell
166
-11,147
-99% -$915K ﹤0.01% 384
2024
Q2
$1.28M Buy
11,313
+131
+1% +$16.6K 0.09% 94
2024
Q1
$1.55M Buy
11,182
+259
+2% +$32.6K 0.12% 86
2023
Q4
$1.36M Buy
10,923
+10,859
+16,967% +$1.11M 0.11% 90
2023
Q3
$5.97K Buy
+64
New +$7.21K ﹤0.01% 337

Other funds holding DXCM

BOK Financial Private Wealth's DXCM Position: Q1 2026 in Review

BOK Financial Private Wealth sold out of DexCom (DXCM) in Q1 2026, closing a stake of 80 shares — an estimated $5.31K sold.

BOK Financial Private Wealth first reported a position in DXCM in Q3 2023 and held it in 6 quarters. The position peaked at $1.55M in Q1 2024. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • BOK Financial Private Wealth reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
  • BOK Financial Private Wealth sold 80 DexCom shares in Q1 2026, an estimated $5.31K.
  • BOK Financial Private Wealth first reported a position in DexCom in Q3 2023 and held it in 6 quarters.
  • BOK Financial Private Wealth's DexCom position peaked at $1.55M in Q1 2024.
  • 957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on BOK Financial Private Wealth's 13F filing for Q1 2026, filed 12 May 2026.